|
|
Home
> CSL Behring - USA Homepage
We are passionate about improving the quality of life for patients with hemophilia, immune deficiency disorders and Alpha-1 antitrypsin (AAT) deficiency. Our life-saving therapies help prevent blood-related diseases in newborns and are used in trauma and surgical care.
21 July 2008CSL Behring Submits BLA for Fibrinogen to U.S. FDA
3 June 2008Study Shows Extended Half-life Recombinant VIIa Leads to Longer Biologic Activity
|